Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-Term Use of Nimotuzumab in Combination With Intensity-Modulated Radiotherapy and Chemotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: Experience of a Single Institution.
Oncol Res. 2018 Mar 5;26(2):277-287. doi: 10.3727/096504017X15079846743590. Epub 2017 Oct 18.
Oncol Res. 2018.
PMID: 29046165
Free PMC article.
Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma.
Fangzheng W, Chuner J, Lei W, Fengqin Y, Zhimin Y, Quanquan S, Tongxin L, Min X, Peng W, Bin L, Aizawa R, Sakamoto M, Zhenfu F.
Fangzheng W, et al. Among authors: fengqin y.
Oncotarget. 2017 Aug 7;8(53):91150-91161. doi: 10.18632/oncotarget.20017. eCollection 2017 Oct 31.
Oncotarget. 2017.
PMID: 29207632
Free PMC article.
Item in Clipboard
Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.
Fangzheng W, Quanquan S, Chuner J, Lei W, Fengqin Y, Zhimin Y, Tongxin L, Min X, Peng W, Haitao J, Aizawa R, Sakamoto M, Yuezhen W, Zhenfu F.
Fangzheng W, et al. Among authors: fengqin y.
Oncotarget. 2017 May 27;8(57):96798-96808. doi: 10.18632/oncotarget.18245. eCollection 2017 Nov 14.
Oncotarget. 2017.
PMID: 29228572
Free PMC article.
Item in Clipboard
Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma.
Wang F, Chuner J, Lei W, Fengqin Y, Zhimin Y, Quanquan S, Tongxin L, Zhenfu F, Yangming J.
Wang F, et al. Among authors: fengqin y.
Medicine (Baltimore). 2020 Sep 25;99(39):e22283. doi: 10.1097/MD.0000000000022283.
Medicine (Baltimore). 2020.
PMID: 32991429
Free PMC article.
Clinical Trial.
Item in Clipboard
The Usefulness of Pretreatment MR-Based Radiomics on Early Response of Neoadjuvant Chemotherapy in Patients With Locally Advanced Nasopharyngeal Carcinoma.
Yongfeng P, Chuner J, Lei W, Fengqin Y, Zhimin Y, Zhenfu F, Haitao J, Yangming J, Fangzheng W.
Yongfeng P, et al. Among authors: fengqin y.
Oncol Res. 2021 Mar 16;28(6):605-613. doi: 10.3727/096504020X16022401878096. Epub 2020 Oct 26.
Oncol Res. 2021.
PMID: 33523792
Free PMC article.
Item in Clipboard
Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis.
Fangzheng W, Chuner J, Zhimin Y, Quanquan S, Tongxin L, Min X, Peng W, Bin L, Sakamoto M, Yuezhen W, Fengqin Y, Zhenfu F, Yangming J.
Fangzheng W, et al. Among authors: fengqin y.
Oncotarget. 2017 Oct 6;8(55):94117-94128. doi: 10.18632/oncotarget.21587. eCollection 2017 Nov 7.
Oncotarget. 2017.
PMID: 29212214
Free PMC article.
Item in Clipboard
Expression and purification of active recombinant human bikunin in Pichia pastoris.
Jian-qiu W, Feng-qin Y, Dou-dou W, Lei B, Nan S, Cong-yan L, Ting Z, Wei-qun Y.
Jian-qiu W, et al.
Protein Expr Purif. 2008 Aug;60(2):127-31. doi: 10.1016/j.pep.2008.03.025. Epub 2008 Apr 4.
Protein Expr Purif. 2008.
PMID: 18501630
Item in Clipboard
Cite
Cite